Skip to content

Clinical Study of Laser-assisted Drug Delivery in the treatment of Hypertrophic Scar

Clinical Study of Laser-assisted Drug Delivery in the treatment of Hypertrophic Scar

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084573
Enrollment
Unknown
Registered
2024-05-20
Start date
2024-05-27
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scar

Interventions

group 1:CO2 fractional laser-assisted betamethasone delivery, CO2 FLABD
group 2:CO2 fractional laser monotherapy, CO2 FLM

Sponsors

Plastic and Cosmetic Center, the 988th Hospital of Joint Support Force
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients with hypertrophic scars, 18~65 years old, at least 3 months. Linear scars were expected to be at least 3cm in length. Patchy scars were at least greater than 3cm2.

Exclusion criteria

Exclusion criteria: Patients with underlying systemic diseases, pregnant women, patients who could not be followed up, patients who could not tolerate the risks of the study, patients who could not give oral and written informed consent, patients who could not communicate normally, patients who had history of laser treatment, hormone and isotretinoin use or exposure to sunlight within 3 months before treatment, keloids, unhealed wounds around scars, and a history of allergy to topical anesthetics.

Design outcomes

Primary

MeasureTime frame
Patient and Observer Scar Assessment Scale;Vancouver scar scale;Visual analogue scale;

Secondary

MeasureTime frame
the Height degree of scar;complication rates;

Countries

China

Contacts

Public ContactZonghui Liu

Plastic and Cosmetic Center, the 988th Hospital of Joint Support Force

123456LZHui@163.com+86 199 3739 4493

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026